Monopar Therapeutics MNPR Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Monopar Therapeutics's investment proceeds?
- Monopar Therapeutics (MNPR) reported investment proceeds of $35.25M in Q1 2026.
- How has Monopar Therapeutics's investment proceeds changed year-over-year?
- Monopar Therapeutics's investment proceeds increased by 2103.4% year-over-year, from $1.6M to $35.25M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.